Amino GmbH Relaunching L-Isoleucine

Amino GmbH Relaunching L-Isoleucine

FRELLSTEDT, GermanyAmino GmbH announced the relaunch of L-Isoleucine, using state-of-the-art fermentation production technology made possible through Ambio, Aminos joint venture with SA Bioproducts. The relaunch of L-Isoleucine marks our first step in the transition from extraction technology to fermentation technology, said Lutz Thomas, managing director of Amino. Traditionally, Amino produced L-Isoleucine by means of extraction.

L-Isoleucine is an essential amino acid that extends anabolic effects in the human muscular system. It may act as an energy supplier during glycogen deficiency and it increases the secretion of insulin. In addition, L-Isoleucine counteracts the excessive formation of serotonin in the brain and is beneficial for liver diseases.

For more information, visit www.aminoactives.com or Booth #1923 at SupplySide West.